Izumisano, Japan

Masumi Furukawa


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masumi Furukawa: Innovator in Antiallergic Compounds

Introduction

Masumi Furukawa is a notable inventor based in Izumisano, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. Her innovative work has led to the creation of compounds that offer potential therapeutic benefits.

Latest Patents

Furukawa holds a patent for "Carbostyril derivatives and antiallergic agent." This patent describes a compound with a specific formula that exhibits antiallergic activity. The compound includes various substituents that enhance its effectiveness in treating allergic reactions. The patent highlights the intricate chemical structure and the potential applications of these compounds in the pharmaceutical industry.

Career Highlights

Masumi Furukawa is currently associated with Sawai Pharmaceutical Co., Ltd. Her work at this company has allowed her to focus on research and development in the field of antiallergic medications. Furukawa's dedication to innovation has positioned her as a key player in her field.

Collaborations

Throughout her career, Furukawa has collaborated with esteemed colleagues, including Takeshi Shogaki and Hiromu Toyoda. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical science.

Conclusion

Masumi Furukawa's contributions to the field of antiallergic agents exemplify her commitment to innovation and research. Her patent for carbostyril derivatives showcases her expertise and the potential impact of her work on allergy treatments. Furukawa continues to be a significant figure in the pharmaceutical industry, driving advancements that benefit many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…